PaulAndrewReyfmanMD

Asthma & COPD, Critical Care Medicine, Interstitial Lung Diseases

Physician

Dr. Reyfman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Galter Pavilion, 675 N St Clair St Ste 18-250
Chicago, IL 60611
Phone+1 312-695-1800

McGaw Medical Center of Northwestern UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2017
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
Columbia University Vagelos College of Physicians and SurgeonsClass of 2011

PubMed

1 citations
Efficacy and safety of gefapixant in women with chronic cough and cough-induced stress urinary incontinence: a phase 3b, randomised, multicentre, double-blind, placebo...
Surinder S Birring, Linda Cardozo, Roger Dmochowski, Peter Dicpinigaitis, Amna Afzal
The Lancet. Respiratory Medicine. 2024-11-01
26 citations
Mitochondrial integrated stress response controls lung epithelial cell fate.
SeungHye Han, Minho Lee, Youngjin Shin, Regina Giovanni, Ram P Chakrabarty
Nature. 2023-08-01
15 citations
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.
Lorcan McGarvey, Mandel Sher, Yury Grigorievich Shvarts, Susan Lu, Wen-Chi Wu
Lung. 2023-04-01

Northwestern Doctor Awarded ATS Foundation/Boehringer Ingelheim Fellowship for IPF ResearchApril 15th, 2019
ATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. Research Fellowship in Idiopathic Pulmonary FibrosisApril 8th, 2019